butyricum, Akkermansia muciniphila, B
Mechanism & Research Background GLP-3 (RT) (LY3437943) is a 39-amino acid synthetic peptide engineered as a triple-receptor agonist with concurrent activity at the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
However, GLP-1 receptors are also expressed in brain regions involved in reward processing, and a GLP-1R variant was found to be associated with increased alcohol use, suggesting a potential role in modulating drug- and alcohol-seeking behavior (Merchenthaler et al
Researchers should interpret the rodent amount protocols summarized below as scientific reference for the published model systems, not as guidance for any other context
Higher glutathione levels are consistently associated with reduced cardiovascular risk